409 related articles for article (PubMed ID: 30627079)
21. Cancer-Related Cachexia: The Vicious Circle between Inflammatory Cytokines, Skeletal Muscle, Lipid Metabolism and the Possible Role of Physical Training.
Mangano GD; Fouani M; D'Amico D; Di Felice V; Barone R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328423
[TBL] [Abstract][Full Text] [Related]
22. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
23. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
Daou HN
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
[TBL] [Abstract][Full Text] [Related]
24. Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting.
Huot JR; Baumfalk D; Resendiz A; Bonetto A; Smuder AJ; Penna F
Antioxid Redox Signal; 2023 Feb; 38(4-6):352-370. PubMed ID: 36310444
[No Abstract] [Full Text] [Related]
25. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression.
das Neves W; Alves CR; de Almeida NR; Guimarães FL; Ramires PR; Brum PC; Lancha AH
Life Sci; 2016 Oct; 163():11-22. PubMed ID: 27575705
[TBL] [Abstract][Full Text] [Related]
26. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
27. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
29. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations.
Pin F; Busquets S; Toledo M; Camperi A; Lopez-Soriano FJ; Costelli P; Argilés JM; Penna F
Oncotarget; 2015 Dec; 6(41):43202-15. PubMed ID: 26636649
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.
Hardee JP; Counts BR; Gao S; VanderVeen BN; Fix DK; Koh HJ; Carson JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):369-383. PubMed ID: 29215198
[TBL] [Abstract][Full Text] [Related]
31. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
32. Cancer cachexia, a clinical challenge.
Argilés JM; Busquets S; López-Soriano FJ
Curr Opin Oncol; 2019 Jul; 31(4):286-290. PubMed ID: 30893144
[TBL] [Abstract][Full Text] [Related]
33. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
34. Repeated eccentric contractions positively regulate muscle oxidative metabolism and protein synthesis during cancer cachexia in mice.
Hardee JP; Fix DK; Koh HJ; Wang X; Goldsmith EC; Carson JA
J Appl Physiol (1985); 2020 Jun; 128(6):1666-1676. PubMed ID: 32407241
[TBL] [Abstract][Full Text] [Related]
35. Cachexia in rheumatoid arthritis.
Walsmith J; Roubenoff R
Int J Cardiol; 2002 Sep; 85(1):89-99. PubMed ID: 12163213
[TBL] [Abstract][Full Text] [Related]
36. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
[TBL] [Abstract][Full Text] [Related]
37. The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention.
Cole CL; Kleckner IR; Jatoi A; Schwarz EM; Dunne RF
JCSM Clin Rep; 2018; 3(2):. PubMed ID: 31134216
[TBL] [Abstract][Full Text] [Related]
38. Understanding sex differences in the regulation of cancer-induced muscle wasting.
Montalvo RN; Counts BR; Carson JA
Curr Opin Support Palliat Care; 2018 Dec; 12(4):394-403. PubMed ID: 30102621
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
Ebner N; Elsner S; Springer J; von Haehling S
Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
[TBL] [Abstract][Full Text] [Related]
40. Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia.
Rausch V; Sala V; Penna F; Porporato PE; Ghigo A
Oncogenesis; 2021 Jan; 10(1):1. PubMed ID: 33419963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]